Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study

被引：0
|
作者：
Shailesh Bihari
Shivesh Prakash
Dani L. Dixon
Elena Cavallaro
Andrew D. Bersten
机构：
[1] Department of ICCU,College of Medicine and Public Health
[2] Flinders Medical Centre,undefined
[3] Flinders University,undefined
来源：
Intensive Care Medicine Experimental | / 9卷
关键词：
ARDS; Hypernatremia; Hyperosmolarity; Lung injury score; Mechanical Ventilation; Randomized control study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
    Zhao, Y.
    Wu, L.
    Lu, Q.
    Gao, X.
    Zhu, X.
    Yao, X.
    Li, L.
    Li, W.
    Ding, Y.
    Song, Z.
    Liu, L.
    Dang, N.
    Zhang, C.
    Liu, X.
    Gu, J.
    Wang, J.
    Geng, S.
    Liu, Q.
    Guo, Y.
    Dong, L.
    Su, H.
    Bai, L.
    O'Malley, J. T.
    Luo, J.
    Laws, E.
    Mannent, L.
    Ruddy, M.
    Amin, N.
    Bansal, A.
    Ota, T.
    Wang, M.
    Zhang, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 633 - 641
  • [32] The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
    Patrick M. Honore
    Aude Mugisha
    Luc Kugener
    Sebastien Redant
    Rachid Attou
    Andrea Gallerani
    David De Bels
    Critical Care, 24
  • [33] The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
    Honore, Patrick M.
    Mugisha, Aude
    Kugener, Luc
    Redant, Sebastien
    Attou, Rachid
    Gallerani, Andrea
    De Bels, David
    CRITICAL CARE, 2020, 24 (01):
  • [34] A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
    Papp, K. A.
    Reich, K.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Krueger, J. G.
    Russell, C. B.
    Milmont, C. E.
    Li, J.
    Klekotka, P. A.
    Kricorian, G.
    Nirula, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 273 - 286
  • [35] Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study
    Prajapati, Vimal H.
    Seyger, Marieke M. B.
    Wilsmann-Theis, Dagmar
    Szakos, Erzsebet
    Kaszuba, Andrzej
    van Hartingsveldt, Bart
    Jett, Meg
    Jiang, Gigi
    Li, Shu
    Sinha, Vikash
    Crauwels, Herta
    Deklotz, Cynthia M. C.
    Paller, Amy S.
    BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (04) : 618 - 628
  • [36] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study
    Kimball, Alexa B.
    Ackerman, Lindsay
    Schlosser, Bethanee J.
    Prajapati, Vimal H.
    Fretzin, Scott
    Takahashi, Hidetoshi
    Zhan, Tianyu
    Huang, Xiaohong
    Camp, Heidi S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB42 - AB42
  • [37] Treatment withdrawal and retreatment with upadacitinib in patients with moderate-to-severe atopic dermatitis from a phase IIb, randomized, controlled trial
    Reich, K.
    Thaci, D.
    Papp, K.
    Anderson, J.
    Hu, X.
    Gu, Y.
    Teixeira, H.
    Guttman-Yassky, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E98 - E99
  • [38] A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
    Spahrkas, S.
    Abraham, K.
    Akbari, F.
    Zenner, H-P.
    Reitsma, H.
    Kuiper, B.
    Schuit, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1004 - S1004
  • [39] A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
    Piper, Edward
    Brightling, Christopher
    Niven, Robert
    Oh, Chad
    Faggioni, Raffaella
    Poon, Kwai
    She, Dewei
    Kell, Chris
    May, Richard D.
    Geba, Gregory P.
    Molfino, Nestor A.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (02) : 330 - 338
  • [40] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852
12345